Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Selective serotonin reuptake inhibitors (SSRIs) are now generally regarded as effective and better tolerated alternatives to tricyclic antidepressants (TCAs) for the treatment of depression. SSRIs also seem to be as well tolerated as moclobemide, mirtazapine, venlafaxine, reboxetine and nefazodone and show comparable efficacy. Minor differences have been observed between some SSRIs and some of the newer antidepressants but these findings are far from conclusive. Widespread use of the SSRIs has highlighted some unforseen adverse effects associated with SSRIs, namely hyponatraemia, EPSE and sexual dysfunction. Overall, differences in efficacy and tolerability between individual SSRIs are small and clinically insignificant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“Patients were assessed using HAMD, MADRS and CGI scales [18-20].”
MethodA new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399 · cited 17×
“A broader and more meaningful question is whether or not SSRIs are better tolerated than the TCAs.”
ResultInfluentialMovement Disorders Associated With the Serotonin Selective Reuptake Inhibitors
Leo, R. J. (1996) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v57n1002 · Cited by 364
Anderson, I. M., & Tomenson, B. M. (1995) · BMJ · doi:10.1136/bmj.310.6992.1433 · Cited by 306
Serotonin Reuptake Inhibitor Withdrawal
Coupland, N. J., Bell, C. J., & Potokar, J. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00003 · Cited by 303 · cited 1×
“Symptom severity seems to be related to treatment duration [47].”
BackgroundClerc, G. E., Ruimy, P., & Verdeau-Paillès, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199409000-00001 · Cited by 298
Selective Serotonin-Reuptake Inhibitor–Induced Movement Disorders
Gerber, P. E., & Lynd, L. D. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17302 · Cited by 267
Nyth, A. L., Gottfries, C. G., Lyby, K., Smedegaard‐Andersen, L., Gylding‐Sabroe, J., Kristensen, M., Refsum, H. ‐., Öfsti, E., Eriksson, S., & Syversen, S. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03242.x · Cited by 258
Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates
Montgomery, S. A., Henry, J., McDonald, G., Dinan, T., Lader, M., Hindmarch, I., Clare, A., & Nutt, D. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400910-00008 · Cited by 254
Sertraline in the Prevention of Depression
Doogan, D. P., & Caillard, V. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.2.217 · Cited by 245
Venlafaxine and paroxetine in treatment-resistant depression: Double-blind, randomised comparison
Poirier, M.-F., & Boyer, P. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.1.12 · Cited by 185
Chouinard, G. (1985) · PubMed · Cited by 184
PRICE, J. S., WALLER, P. C., WOOD, S. M., & MACKAY, A. V. P. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.00498.x · Cited by 171 · cited 1×
“Because of the different ways in which the data was collected, we cannot draw any firm conclusions [48].”
BackgroundVenlafaxine and paroxetine in treatment-resistant depression
Gregson, J. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.6.591a · Cited by 171
SSRI-associated nocturnal bruxism in four patients.
Ellison, J. M., & Stanziani, P. J. (1993) · PubMed · Cited by 167
Montgomery, S. A., Rasmussen, J. G. C., & Tanghøj, P. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00008 · Cited by 163
Wheatley, D. P., Moffaert, M. V., Timmerman, L., & Kremer, C. M. E. (1998) · PubMed · Cited by 157
Dieric, M., Ravizza, U., Realini, R., & Martin, A. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00292-8 · Cited by 152 · cited 4×
“study [17], no correction factor was applied for repeated statistical testing nor was a sample size calculated before starting the study [17].”
BackgroundMethodResultInfluentialWheatley, D. P., van Moffaert, M., Timmerman, L., Kremer, C. M. E., & The Mirtazapine-Fluoxetine Study Group (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0606 · Cited by 145
Hotopf, M., Hardy, R., & Lewis, G. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.2.120 · Cited by 142
A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Jb, C., & Wilcox, C. M. (1985) · PubMed · Cited by 133
Lydiard, R. B., Stahl, S. M., Hertzman, M., & Harrison, W. M. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1104 · Cited by 126
Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder
Massana, J., M??llerb, H.-J., Burrows, G. D., & Montenegro, R. M. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199903000-00003 · Cited by 117
Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression
Aguglia, E., Casacchia, M., Cassano, G. B., Faravelli, C., Ferrari, G., Giordano, P., Pancheri, P., Ravizza, L., Trabucchi, M., Bolino, F., et al. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00010 · Cited by 115
De Wilde, J., Spiers, R., Mertens, C., Bartholomé, F., Schotte, G., & Leyman, S. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03345.x · Cited by 111
Pharmacokinetics of the newer antidepressants: Clinical relevance
DeVane, C. L. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90359-x · Cited by 110
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system
Stahl, M. M. S., Lindquist, M., Pettersson, M., Edwards, I. R., Sanderson, J. H., Taylor, N. F. A., Fletcher, A. P., & Schou, J. S. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050357 · Cited by 97
e Silva, J. C. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0703 · Cited by 94
Ekselius, L., von Knorring, L., & Eberhard, G. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199711000-00005 · Cited by 91
A Double-Blind Comparison of Fluvoxamine and Paroxetine in the Treatment of Depressed Outpatients
Kiev, A., & Feiger, A. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0402 · Cited by 89
Patris, M., Bouchard, J.-M., Bougerol, T., Charbonnier, J.-F., Chevalier, J.-F., Clerc, G., Cyran, C., Van Amerongen, P., Lemming, O., & Petersen, H. E. H. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606000-00007 · Cited by 85
Safety of Abrupt Discontinuation of Fluoxetine: A Randomized, Placebo-Controlled Study
Zajecka, J., Fawcett, J., Amsterdam, J., Quitkin, F., Reimherr, F., Rosenbaum, J., Michelson, D., & Beasley, C. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199806000-00003 · Cited by 85
A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo in Outpatients with Major Depression
Fava, M., Amsterdam, J. D., Deltito, J. A., Salzman, C., Schwaller, M., & Dünner, D. L. (1998) · Annals of Clinical Psychiatry · doi:10.1023/a:1022337927842 · Cited by 81
Possible Paroxetine-Induced Bruxism
Romanelli, F., Adler, D. A., & Bungay, K. M. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603001107 · Cited by 74
Geretsegger, C., Böhmer, F., & Ludwig, M. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400910-00004 · Cited by 73
A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
Feighner, J. P. (1985) · PubMed · Cited by 70
Terra, J.-L., & Montgomery, S. (1998) · PubMed · Cited by 66
Doogan, D. P., & Langdon, C. J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400920-00005 · Cited by 60
Pharmacokinetic Optimisation of Therapy with Newer Antidepressants
Goodnick, P. J. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427040-00005 · Cited by 58
Rosenberg, C., Damsbo, N., Fuglum, E., Jacobsen, L. V., & Horsgård, S. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00007 · Cited by 58
A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders
Williams, R., Edwards, R. A., Newburn, G. M., Mullen, R., Menkes, D. B., & Segkar, C. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300730-00006 · Cited by 52
Terra, J. L., & Montgomery, S. A. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199803000-00001 · Cited by 51
Nemeroff, C. B., Ninan, P. T., Ballenger, J., Lydiard, R. B., Feighner, J., Patterson, W. M., & Greist, J. H. (1995) · Depression · doi:10.1002/depr.3050030402 · Cited by 51
A Comparison of Fluvoxamine and Fluoxetine in the Treatment of Major Depression
Rapaport, M., Coccaro, E., Sheline, Y., Perse, T., Holland, P., Fabre, L., & Bradford, D. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00005 · Cited by 49
Franchini, L., Gasperini, M., Perez, J., Smeraldi, E., & Zanardi, R. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0303 · Cited by 48
A Comparison of Fluoxetine and Amitriptyline in the Treatment of Major Depression
KEEGAN, D., BOWEN, R. C., BLACKSHAW, S., SALEH, S., DAYAL, N., REMILLARD, F., SHRIKHANDE, S., PEREZ, S. C., BOULTON, A., RICHARDSON, S., et al. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100620-00007 · Cited by 46
A comparison of paroxetine and placebo in depressed outpatients
Dunbar, G. C., Claghorn, J. L., Kiev, A., Rickels, K., & Smith, W. T. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03376.x · Cited by 42
Fluoxetine versus trazodone in the treatment of outpatients with major depression.
Debus, J. R., Rush, A. J., Himmel, C., Tyler, D., Polatin, P. B., & Weissenburger, J. E. (1988) · PubMed · Cited by 41
A comparative trial of fluoxetine versus trazodone in outpatients with major depression.
Perry, P. J., Garvey, M. J., Kelly, M. W., Cook, B. L., Dunner, F. J., & Winokur, G. (1989) · PubMed · Cited by 40
Suboptimal Use of Antidepressants in the Treatment of Depression
Donoghue, J., & Taylor, D. M. (2000) · CNS Drugs · doi:10.2165/00023210-200013050-00006 · Cited by 39
Self-citationHeiligenstein, J. H., Tollefson, G. D., & Faries, D. E. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00007 · Cited by 37
Möller, H.-J., Gallinat, J., Hegerl, U., Arató, M., Janka, Z., Pflug, B., & Bauer, H. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979323 · Cited by 35
Moclobemide versus fluoxetine for a major depressive episode
Reynaert, C., Janne, P., Parent, M., Mirel, J., & Hazzen, L. (1995) · Psychopharmacology · doi:10.1007/bf02245838 · Cited by 32
Nielsen, B. M., Behnke, K., Arup, P., Christiansen, P. E., Geisler, A. E., Ipsen, E. Ø., Maach‐Møller, B., & Øhrberg, S. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03370.x · Cited by 32
Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trial
Beasley, C. M., Sayler, M. E., & Potvin, J. H. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00002 · Cited by 30
Arminen, S.-L., Ikonen, U., Pulkkinen, P., Leinonen, E. V. J., Mahlanen, A., Koponen, H., Kourula, K., Ryyppö, J., Korpela, V., Lehtonen, M. L., et al. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01533.x · Cited by 30
Olié, J. P., Gunn, K. P., & Katz, E. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)86377-8 · Cited by 26
Rahman, M. K., Mj, A., Savla, N., Sharma, R. R., Kellett, J. M., & Ashford, J. J. (1991) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1991.tb08868.x · Cited by 26
Moclobemide versus fluoxetine for double depression: A randomized double-blind study
Duarte, A., Mikkelsen, H., & Delini‐Stula, A. (1996) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00030-1 · Cited by 20
A Double-blind Multi-centre Trial of Fluoxetine and Dothiepin in Major Depressive Illness
SOUTH WALES ANTIDEPRESSANT DRUG TRIAL GROUP (1988) · International Clinical Psychopharmacology · doi:10.1097/00004850-198801000-00006 · Cited by 19
Placebo‐Controlled trial of paroxetine in depressive illness
Edwards, J. G., & Goldie, A. (1993) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.470080306 · Cited by 14
Sexual adverse effects with new antidepressants
Mir, S., & Taylor, D. M. (1998) · Psychiatric Bulletin · doi:10.1192/pb.22.7.438 · Cited by 12
Self-citation
Cited by
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052963 · Cited by 1,033
Hatem, S. M., Saussez, G., della Faille, M., Prist, V., Zhang, X., Dispa, D., & Bleyenheuft, Y. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00442 · Cited by 918
New insights into symptoms and neurocircuit function of anorexia nervosa
Kaye, W. H., Fudge, J. L., & Paulus, M. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2682 · Cited by 843
Metadata
- Authors
- Mace, S., & Taylor, D.
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa UK Limited
- Published
- 2000-07
- Volume
- 1
- Issue
- 5
- Pages
- 917-933
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W2035951223
- Cited by
- 315
- References
- 64
- FWCI
- 16.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.